NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype

Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms

(2020) Tsai-Tsen Liao et al.   Cells

A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker

(2020) Louis Godin et al.   Cancers

Collective cell migration and metastases induced by an epithelial-to-mesenchymal transition in Drosophila intestinal tumors

(2019) Kyra Campbell et al.   Nature Communications

A biophysical model uncovers the size distribution of migrating cell clusters across cancer types

(2019) Federico Bocci et al.   CANCER RESEARCH

Dynamics of Phenotypic Heterogeneity during EMT and Stemness in Cancer Progression

(2019) Jolly et al.   Journal of Clinical Medicine

Hybrid epithelial/mesenchymal phenotype(s): The ‘fittest’ for metastasis?

(2018) Mohit Kumar Jolly et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize

(2018) Mario Giuliano et al.   CANCER RESEARCH

Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity

(2018) Mohit Kumar Jolly et al.   Frontiers in Oncology

EMT Transition States during Tumor Progression and Metastasis

(2018) Ievgenia Pastushenko et al.   TRENDS IN CELL BIOLOGY

Numb prevents a complete epithelial–mesenchymal transition by modulating Notch signalling

(2017) Federico Bocci et al.   Journal of the Royal Society Interface

Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?

(2017) Mohit Kumar Jolly et al.   Molecular Oncology

NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma

(2017) Zhi-Jie Xiao et al.   eLife

Phenotypic plasticity in prostate cancer: role of intrinsically disordered proteins

(2016) StevenM Mooney et al.   ASIAN JOURNAL OF ANDROLOGY

EMT: 2016

(2016) M. Angela Nieto et al.   CELL

Distinctive properties of metastasis-initiating cells

(2016) Toni Celià-Terrassa et al.   GENES & DEVELOPMENT

Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2

(2016) Jason A. Somarelli et al.   MOLECULAR AND CELLULAR BIOLOGY

Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player

(2016) G P Mognol et al.   Cell Death & Disease

Stability of the hybrid epithelial/mesenchymal phenotype

(2016) Mohit Kumar Jolly et al.   Oncotarget

Population Heterogeneity in the Epithelial to Mesenchymal Transition Is Controlled by NFAT and Phosphorylated Sp1

(2016) Russell Gould et al.   PLoS Computational Biology

Nonsense-Mediated RNA Decay Influences Human Embryonic Stem Cell Fate

(2016) Chih-Hong Lou et al.   Stem Cell Reports

Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity

(2015) S. K. Singh et al.   EMBO JOURNAL

The calcineurin/NFAT pathway is activated in diagnostic breast cancer cases and is essential to survival and metastasis of mammary cancer cells

(2015) C Tran Quang et al.   Cell Death & Disease

OVOL guides the epithelial-hybrid-mesenchymal transition

(2015) Dongya Jia et al.   Oncotarget

An Ovol2-Zeb1 Mutual Inhibitory Circuit Governs Bidirectional and Multi-step Transition between Epithelial and Mesenchymal States

(2015) Tian Hong et al.   PLoS Computational Biology

PROGgeneV2: enhancements on the existing database

(2015) Chirayu Pankaj Goswami et al.   BMC CANCER

NFAT as cancer target: Mission possible?

(2014) Jiang-Jiang Qin et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Nuclear Factor of Activated T-cell Activity Is Associated with Metastatic Capacity in Colon Cancer

(2014) M. K. Tripathi et al.   CANCER RESEARCH

Mammary Morphogenesis and Regeneration Require the Inhibition of EMT at Terminal End Buds by Ovol2 Transcriptional Repressor

(2014) Kazuhide Watanabe et al.   DEVELOPMENTAL CELL

Ovol Proteins: Guardians against EMT during Epithelial Differentiation

(2014) Shan Li et al.   DEVELOPMENTAL CELL

Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions

(2014) J. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Signaling mechanisms of the epithelial-mesenchymal transition

(2014) D. M. Gonzalez et al.   Science Signaling

Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation

(2013) G. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination

(2013) M. Lu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nfatc1 directs the endocardial progenitor cells to make heart valve primordium

(2013) Bingruo Wu et al.   TRENDS IN CARDIOVASCULAR MEDICINE

miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions

(2012) Helge Siemens et al.   CELL CYCLE

Cellular Decision Making and Biological Noise: From Microbes to Mammals

(2011) Gábor Balázsi et al.   CELL

Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells

(2011) Piyush B. Gupta et al.   CELL

Nfatc1 Coordinates Valve Endocardial Cell Lineage Development Required for Heart Valve Formation

(2011) Bingruo Wu et al.   CIRCULATION RESEARCH

The calcineurin/NFAT signaling pathway: A NOVEL therapeutic target in leukemia and solid tumors

(2010) Hind Medyouf et al.   CELL CYCLE

E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer

(2009) Otto Schmalhofer et al.   CANCER AND METASTASIS REVIEWS

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

(2008) Ulrike Burk et al.   EMBO REPORTS

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

(2008) S.-M. Park et al.   GENES & DEVELOPMENT